Workplace exposures and the risk of amyotrophic lateral sclerosis

Environmental Health Perspectives

Volumn 117, Issue 9, 2009, Pages 1387-1392

  Fang, Fang ^a,b   Quinlan, Patricia ^c   Ye, Weimin ^b   Barber, Marie K ^d   Umbach, David M ^a   Sandler, Dale P ^a   Kamel, Freya ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WESTAT   (United States)

Author keywords

Amyotrophic lateral sclerosis; Chemicals; Relative risk; Risk factors; Workplace exposures

Indexed keywords

CHLORINATED HYDROCARBON; GLYCOL; HEXANE; INDUSTRIAL CHEMICAL; LUBRICATING AGENT;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BUILDING INDUSTRY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; INDUSTRIAL WORKER; MAJOR CLINICAL STUDY; MALE; METAL INDUSTRY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SMOKING; STATISTICAL MODEL; STRUCTURED INTERVIEW; UNITED STATES; WORKPLACE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RISK FACTORS; WORKPLACE;

EID: 69949175698     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0900580     Document Type: Article

References (39)

1. Agency for Toxic Substances and Disease Registry. 1999. Toxicological Profile for Formaldehyde. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
2. Armon C. 2001. Environmental risk factors for amyotrophic lateral sclerosis. Neuroepidemiology 20:2-6.
3. Breland AE Jr, Currier RD. 1967. Multiple sclerosis and amyotrophic lateral sclerosis in Mississippi. Neurology 17:1011-1016.
4. Brooks BR. 1994. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124(suppl):96-107.
5. Canesi M, Perbellini L, Maestri L, Silvani A, Zecca L, Bet L, et al. 2003. Poor metabolization of n-hexane in Parkinson's disease. J Neurol 250:556-560.
6. Chancellor AM, Slattery JM, Fraser H, Warlow CP. 1993. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 56:1200-1206.
7. Chang YC. 1990. Patients with n-hexane induced polyneuropathy: a clinical follow up. Br J Ind Med 47:485-489.
8. Chio A. 2000. Risk factors in the early diagnosis of ALS: European epidemiological studies. Amyotroph Lateral Scler Other Motor Neuron Disord 1(suppl 1):S13-S18.
9. Chio A, Meineri P, Tribolo A, Schiffer D. 1991. Risk factors in motor neuron disease: a case-control study. Neuroepidemiology 10:174-184.
10. Fang F, Bellocco R, Hernán MA, Ye W. 2006. Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis - a prospective cohort study. Neuroepidemiology 27:217-221.
11. Gait R, Maginnis C, Lewis S, Pickering N, Antoniak M, Hubbard R, et al. 2003. Occupational exposure to metals and solvents and the risk of motor neuron disease. A case-control study. Neuroepidemiology 22:353-356.
12. Granieri E, Carreras M, Tola R, Paolino E, Tralli G, Eleopra R, et al. 1988. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology 38:1604-1608.
13. Gunnarsson LG, Bodin L, Soderfeldt B, Axelson O. 1992. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med 49:791-798.
14. Gunnarsson LG, Lindberg G, Soderfeldt B, Axelson O. 1991. Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand 83:394-398.
15. Hess R, Bartels MJ, Pottenger LH. 2004. Ethylene glycol: an estimate of tolerable levels of exposure based on a review of animal and human data. Arch Toxicol 78:671-680.
16. Horner RD, Grambow SC, Coffman CJ, Lindquist JH, Oddone EZ, Allen KD, et al. 2008. Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology 31:28-32.
17. Kadiiska MB, Mason RP. 2000. Ethylene glycol generates free radical metabolites in rats: an ESR in vivo spin trapping investigation. Chem Res Toxicol 13:1187-1191.
18. Kamel F, Umbach DM, Hu H, Munsat TL, Shefner JM, Taylor JA, et al. 2005. Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis 2:195-201.
19. Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP. 2002. Lead exposure and amyotrophic lateral sclerosis. Epidemiology 13:311-319.
20. Kamel F, Umbach DM, Munsat TL, Shefner JM, Sandler DP. 1999. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology 18:194-202.
21. Kamel F, Umbach DM, Stallone L, Richards M, Hu H, Sandler DP. 2008. Association of lead exposure with survival in amyotrophic lateral sclerosis. Environ Health Perspect 116:943-947.
22. Lee JR, Annegers JF, Appel SH. 1995. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 132:207-215.
23. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. 2008. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79:6-11.
24. McGuire V, Longstreth WT Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, et al. 1997. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol 145:1076-1088.
25. Mitchell JD. 2000. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 1:235-250.
26. Morahan JM, Pamphlett R. 2006. Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control study. Neuroepidemiology 27:130-135.
27. Nelson LM. 1995. Epidemiology of ALS. Clin Neurosci 3:327-331.
28. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. 2000. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 15:156-163.
29. Ritchie GD, Rossi J III, Nordholm AF, Still KR, Carpenter RL, Wenger GR, et al. 2001a. Effects of repeated exposure to JP-8 jet fuel vapor on learning of simple and difficult operant tasks by rats. J Toxicol Environ Health A 64:385-415.
30. Ritchie GD, Still KR, Alexander WK, Nordholm AF, Wilson CL, Rossi J III, et al. 2001b. A review of the neurotoxicity risk of selected hydrocarbon fuels. J Toxicol Environ Health B Crit Rev 4:223-312.
31. Schulte PA, Burnett CA, Boeniger MF, Johnson J. 1996. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. Am J Public Health 86:1281-1288.
32. Stayner L, Steenland K, Dosemeci M, Hertz-Picciotto I. 2003. Attenuation of exposure-response curves in occupational cohort studies at high exposure levels. Scand J Work Environ Health 29:317-324.
33. Sutedja NA, Veldink JH, Fischer K, Kromhout H, Wokke JH, Huisman MH, et al. 2007. Lifetime occupation, education, smoking, and risk of ALS. Neurology 69:1508-1514.
34. U.S. Bureau of Labor Statistics. 2008. 1990 Census Industrial and Occupational Classification Codes. Available: http://www.bls.gov/nls/ quex/r1/y97r1cbka1.pdf [accessed 30 August 2008].
35. Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. 2004. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol 160:26-33.
36. Weisskopf MG, McCullough ML, Morozova N, Calle EE, Thun MJ, Ascherio A. 2005a. Prospective study of occupation and amyotrophic lateral sclerosis mortality. Am J Epidemiol 162:1146-1152.
37. Weisskopf MG, Morozova N, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, et al. 2009. Prospective study of chemical exposures and amyotrophic lateral sclerosis mortality. J Neurol Neurosurg Psychiatry 80:558-561.
38. Weisskopf MG, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, et al. 2005b. Prospective study of military service and mortality from ALS. Neurology 64:32-37.
39. Zhang Y, Liu Q, Duan H, Cheng J, Jiang S, Huang X, et al. 2006. Association between metabolic gene polymorphisms and susceptibility to peripheral nerve damage in workers exposed to n-hexane: a preliminary study. Biomarkers 11:61-69.